primary antibodies targeting cd68 Search Results


mouse anti-human cd68 monoclonal antibody msk055 kp-1  (Zytomed Inc)
90
Zytomed Inc mouse anti-human cd68 monoclonal antibody msk055 kp-1
Comparison of number of <t> CD68 </t> + and stabilin-1-positive cells in cancer tissue and remote non-cancerous tissue of primary gastric cancer.
Mouse Anti Human Cd68 Monoclonal Antibody Msk055 Kp 1, supplied by Zytomed Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/mouse anti-human cd68 monoclonal antibody msk055 kp-1/product/Zytomed Inc
Average 90 stars, based on 1 article reviews
mouse anti-human cd68 monoclonal antibody msk055 kp-1 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
anti cd68 primary antibody (1/1000 v/v)  (Euromedex)
90
Euromedex anti cd68 primary antibody (1/1000 v/v)
Comparison of number of <t> CD68 </t> + and stabilin-1-positive cells in cancer tissue and remote non-cancerous tissue of primary gastric cancer.
Anti Cd68 Primary Antibody (1/1000 V/V), supplied by Euromedex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti cd68 primary antibody (1/1000 v/v)/product/Euromedex
Average 90 stars, based on 1 article reviews
anti cd68 primary antibody (1/1000 v/v) - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
antibodies targeting cd68, psgl-1 (cd162), cd163  (Enzo Biochem)
90
Enzo Biochem antibodies targeting cd68, psgl-1 (cd162), cd163
Immunophenotyping of circulating monocytes and impact of steroid medication. ( a ) mean fluorescence intensities (MFI) of CD55, CD97, <t>CD163,</t> CD169, CD204, CD273, CD276, HLA-ABC, and HLA-DR on circulating monocytes of glioblastoma patients (GBM) compared to healthy individuals; ( b ) quantification of PSGL-1, <t>CD163,</t> and HLA-DR expression on circulating monocytes in GBM patients with Dexamethasone medication or without; ( c – e ) Pearson’s correlation of PSGL-1 ( c ), CD163 ( d ), or HLA-DR ( e ) expression with the cumulative doses of dexamethasone given to the GBM patients prior to blood withdrawal. Statistical analysis was performed using paired t -test (* p < 0.05). ns = non-significant. dexa = dexamethasone.
Antibodies Targeting Cd68, Psgl 1 (Cd162), Cd163, supplied by Enzo Biochem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antibodies targeting cd68, psgl-1 (cd162), cd163/product/Enzo Biochem
Average 90 stars, based on 1 article reviews
antibodies targeting cd68, psgl-1 (cd162), cd163 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
cd20 targets  (ILSBio Inc)
90
ILSBio Inc cd20 targets
Immunophenotyping of circulating monocytes and impact of steroid medication. ( a ) mean fluorescence intensities (MFI) of CD55, CD97, <t>CD163,</t> CD169, CD204, CD273, CD276, HLA-ABC, and HLA-DR on circulating monocytes of glioblastoma patients (GBM) compared to healthy individuals; ( b ) quantification of PSGL-1, <t>CD163,</t> and HLA-DR expression on circulating monocytes in GBM patients with Dexamethasone medication or without; ( c – e ) Pearson’s correlation of PSGL-1 ( c ), CD163 ( d ), or HLA-DR ( e ) expression with the cumulative doses of dexamethasone given to the GBM patients prior to blood withdrawal. Statistical analysis was performed using paired t -test (* p < 0.05). ns = non-significant. dexa = dexamethasone.
Cd20 Targets, supplied by ILSBio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cd20 targets/product/ILSBio Inc
Average 90 stars, based on 1 article reviews
cd20 targets - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Comparison of number of CD68 + and stabilin-1-positive cells in cancer tissue and remote non-cancerous tissue of primary gastric cancer.

Journal: Oncology Letters

Article Title: Accumulation of stabilin-1 positive macrophages in the early stage of gastric cancer is associated with short cumulative survival

doi: 10.3892/ol.2020.11310

Figure Lengend Snippet: Comparison of number of CD68 + and stabilin-1-positive cells in cancer tissue and remote non-cancerous tissue of primary gastric cancer.

Article Snippet: The following primary antibodies were used: Mouse anti-human CD68 monoclonal antibody (1:50; cat. no. MSK055 KP-1; Zytomed Systems GmbH), rabbit anti-human stabilin-1 polyclonal antibody (2 μg/ml; 1:800; clone number #27606), kindly provided by Professor Julia Kzhyshkowska (Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, University of Heidelberg, Germany), goat anti-human CD163 antibody (1:200; cat. no. 1607; R&D Systems Europe, Ltd.) and goat anti-human SPARC polyclonal antibody (1:60; cat. no. AF941; R&D Systems, Inc.).

Techniques: Comparison

Expression of stabilin-1 by CD68 + macrophages in human gastric adenocarcinoma. Stabilin-1 was detected by rabbit anti-human stabilin-1 polyclonal antibody and Alexa Fluor 488-conjugated donkey anti-rabbit IgG (indicated in green). CD68 was detected by mouse anti-human CD68 monoclonal antibody and Cy3-conjugated donkey anti-mouse IgG (indicated in red). Nuclei were stained with DRAQ5 (indicated in blue). (A) Stabilin-1-negative/CD68 + cells in poorly gastric adenocarcinoma. Scale bar, 25 µm. (B) Stabilin-1-negative/CD68 + and stabilin-1-positive/CD68 + cells in moderately differentiated gastric adenocarcinoma. Scale bar, 25 µm. (C) Stabilin-1-positive/CD68 + cells in well differentiated gastric adenocarcinoma. Scale bar, 25 µm. (D) Typical stabilin-1-positive/CD68 + cell in moderately differentiated adenocarcinoma. Scale bar, 10 µm.

Journal: Oncology Letters

Article Title: Accumulation of stabilin-1 positive macrophages in the early stage of gastric cancer is associated with short cumulative survival

doi: 10.3892/ol.2020.11310

Figure Lengend Snippet: Expression of stabilin-1 by CD68 + macrophages in human gastric adenocarcinoma. Stabilin-1 was detected by rabbit anti-human stabilin-1 polyclonal antibody and Alexa Fluor 488-conjugated donkey anti-rabbit IgG (indicated in green). CD68 was detected by mouse anti-human CD68 monoclonal antibody and Cy3-conjugated donkey anti-mouse IgG (indicated in red). Nuclei were stained with DRAQ5 (indicated in blue). (A) Stabilin-1-negative/CD68 + cells in poorly gastric adenocarcinoma. Scale bar, 25 µm. (B) Stabilin-1-negative/CD68 + and stabilin-1-positive/CD68 + cells in moderately differentiated gastric adenocarcinoma. Scale bar, 25 µm. (C) Stabilin-1-positive/CD68 + cells in well differentiated gastric adenocarcinoma. Scale bar, 25 µm. (D) Typical stabilin-1-positive/CD68 + cell in moderately differentiated adenocarcinoma. Scale bar, 10 µm.

Article Snippet: The following primary antibodies were used: Mouse anti-human CD68 monoclonal antibody (1:50; cat. no. MSK055 KP-1; Zytomed Systems GmbH), rabbit anti-human stabilin-1 polyclonal antibody (2 μg/ml; 1:800; clone number #27606), kindly provided by Professor Julia Kzhyshkowska (Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, University of Heidelberg, Germany), goat anti-human CD163 antibody (1:200; cat. no. 1607; R&D Systems Europe, Ltd.) and goat anti-human SPARC polyclonal antibody (1:60; cat. no. AF941; R&D Systems, Inc.).

Techniques: Expressing, Staining

Expression of stabilin-1 by CD68 + /CD163 + macrophages in human gastric adenocarcinoma demonstrated by immunofluorescence staining. Stabilin-1 was detected by rabbit anti-human stabilin-1 polyclonal antibody and Alexa Fluor 488-conjugated donkey anti-rabbit IgG (indicated in green). CD163 was detected by goat anti-human CD163 antibody Cy3-conjugated donkey anti-goat IgG (indicated in red). CD68 was detected by mouse anti-human CD68 monoclonal antibody and Alexa Fluor 647-conjugated donkey anti-mouse IgG (indicated in blue). (A) CD68 + /CD163 + /stabilin-1- negative macrophages in gastric adenocarcinoma. Scale bar, 25 µm. (B) CD68 + /CD163 low /stabilin-1-positive macrophages in gastric adenocarcinoma. Scale bar, 25 µm. (C) CD68 + /CD163 low /stabilin-1-positive and CD68 + /CD163 + /stabilin-1-positive cells in gastric adenocarcinoma. Scale bar, 25 µm. (D) Single CD68 + /CD163 + /stabilin-1-positive cell in gastric adenocarcinoma. Scale bar, 2.5 µm.

Journal: Oncology Letters

Article Title: Accumulation of stabilin-1 positive macrophages in the early stage of gastric cancer is associated with short cumulative survival

doi: 10.3892/ol.2020.11310

Figure Lengend Snippet: Expression of stabilin-1 by CD68 + /CD163 + macrophages in human gastric adenocarcinoma demonstrated by immunofluorescence staining. Stabilin-1 was detected by rabbit anti-human stabilin-1 polyclonal antibody and Alexa Fluor 488-conjugated donkey anti-rabbit IgG (indicated in green). CD163 was detected by goat anti-human CD163 antibody Cy3-conjugated donkey anti-goat IgG (indicated in red). CD68 was detected by mouse anti-human CD68 monoclonal antibody and Alexa Fluor 647-conjugated donkey anti-mouse IgG (indicated in blue). (A) CD68 + /CD163 + /stabilin-1- negative macrophages in gastric adenocarcinoma. Scale bar, 25 µm. (B) CD68 + /CD163 low /stabilin-1-positive macrophages in gastric adenocarcinoma. Scale bar, 25 µm. (C) CD68 + /CD163 low /stabilin-1-positive and CD68 + /CD163 + /stabilin-1-positive cells in gastric adenocarcinoma. Scale bar, 25 µm. (D) Single CD68 + /CD163 + /stabilin-1-positive cell in gastric adenocarcinoma. Scale bar, 2.5 µm.

Article Snippet: The following primary antibodies were used: Mouse anti-human CD68 monoclonal antibody (1:50; cat. no. MSK055 KP-1; Zytomed Systems GmbH), rabbit anti-human stabilin-1 polyclonal antibody (2 μg/ml; 1:800; clone number #27606), kindly provided by Professor Julia Kzhyshkowska (Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, University of Heidelberg, Germany), goat anti-human CD163 antibody (1:200; cat. no. 1607; R&D Systems Europe, Ltd.) and goat anti-human SPARC polyclonal antibody (1:60; cat. no. AF941; R&D Systems, Inc.).

Techniques: Expressing, Immunofluorescence, Staining

Association of stabilin-1 and CD68 expression in TNM stage I gastric cancer with cumulative patient survival. Kaplan-Meier analysis and a log rank test were used to compare patient survival with low and high numbers of intratumoral stabilin-1-positive and CD68 + cells. (A) The association of stabilin-1 expression with patient survival. (B) The association of CD68 expression with patient survival. The cutoff value for determining CD68 and stabilin-1 expression as low and high expression was 16.2 cells and 8.0 cells, respectively. TNM, Tumor-Node-Metastasis; Cum, cumulative.

Journal: Oncology Letters

Article Title: Accumulation of stabilin-1 positive macrophages in the early stage of gastric cancer is associated with short cumulative survival

doi: 10.3892/ol.2020.11310

Figure Lengend Snippet: Association of stabilin-1 and CD68 expression in TNM stage I gastric cancer with cumulative patient survival. Kaplan-Meier analysis and a log rank test were used to compare patient survival with low and high numbers of intratumoral stabilin-1-positive and CD68 + cells. (A) The association of stabilin-1 expression with patient survival. (B) The association of CD68 expression with patient survival. The cutoff value for determining CD68 and stabilin-1 expression as low and high expression was 16.2 cells and 8.0 cells, respectively. TNM, Tumor-Node-Metastasis; Cum, cumulative.

Article Snippet: The following primary antibodies were used: Mouse anti-human CD68 monoclonal antibody (1:50; cat. no. MSK055 KP-1; Zytomed Systems GmbH), rabbit anti-human stabilin-1 polyclonal antibody (2 μg/ml; 1:800; clone number #27606), kindly provided by Professor Julia Kzhyshkowska (Institute of Transfusion Medicine and Immunology, Medical Faculty Mannheim, University of Heidelberg, Germany), goat anti-human CD163 antibody (1:200; cat. no. 1607; R&D Systems Europe, Ltd.) and goat anti-human SPARC polyclonal antibody (1:60; cat. no. AF941; R&D Systems, Inc.).

Techniques: Expressing

Immunophenotyping of circulating monocytes and impact of steroid medication. ( a ) mean fluorescence intensities (MFI) of CD55, CD97, CD163, CD169, CD204, CD273, CD276, HLA-ABC, and HLA-DR on circulating monocytes of glioblastoma patients (GBM) compared to healthy individuals; ( b ) quantification of PSGL-1, CD163, and HLA-DR expression on circulating monocytes in GBM patients with Dexamethasone medication or without; ( c – e ) Pearson’s correlation of PSGL-1 ( c ), CD163 ( d ), or HLA-DR ( e ) expression with the cumulative doses of dexamethasone given to the GBM patients prior to blood withdrawal. Statistical analysis was performed using paired t -test (* p < 0.05). ns = non-significant. dexa = dexamethasone.

Journal: Cancers

Article Title: Immunophenotyping of Circulating and Intratumoral Myeloid and T Cells in Glioblastoma Patients

doi: 10.3390/cancers14235751

Figure Lengend Snippet: Immunophenotyping of circulating monocytes and impact of steroid medication. ( a ) mean fluorescence intensities (MFI) of CD55, CD97, CD163, CD169, CD204, CD273, CD276, HLA-ABC, and HLA-DR on circulating monocytes of glioblastoma patients (GBM) compared to healthy individuals; ( b ) quantification of PSGL-1, CD163, and HLA-DR expression on circulating monocytes in GBM patients with Dexamethasone medication or without; ( c – e ) Pearson’s correlation of PSGL-1 ( c ), CD163 ( d ), or HLA-DR ( e ) expression with the cumulative doses of dexamethasone given to the GBM patients prior to blood withdrawal. Statistical analysis was performed using paired t -test (* p < 0.05). ns = non-significant. dexa = dexamethasone.

Article Snippet: Before imaging by light microscopy, sections were incubated with antibodies targeting CD68, PSGL-1 (CD162), and CD163 (dilution 1:50; Enzo Life Sciences, Lörrach, Germany) overnight at 4 °C.

Techniques: Fluorescence, Expressing

List of antibodies used in this study.

Journal: Cancers

Article Title: Immunophenotyping of Circulating and Intratumoral Myeloid and T Cells in Glioblastoma Patients

doi: 10.3390/cancers14235751

Figure Lengend Snippet: List of antibodies used in this study.

Article Snippet: Before imaging by light microscopy, sections were incubated with antibodies targeting CD68, PSGL-1 (CD162), and CD163 (dilution 1:50; Enzo Life Sciences, Lörrach, Germany) overnight at 4 °C.

Techniques: Staining, Flow Cytometry

Myeloid immune infiltration in glioblastoma tumors. ( a ) schematic overview of intratumoral immune profiling after neurosurgical resection of tumor samples; ( b ) absolute numbers of myeloid cells in tumor samples; ( c ) surface expression of PSGL-1 and PD1 on intratumoral myeloid cells; ( d ) comparison of PSGL-1 and PD1 expression on circulating and tumor-infiltrating myeloid cells; ( e ) Pearson’s correlation of PSGL-1 and PD1 expression on circulating and tumor-infiltrating myeloid cells; ( f – k ) representative immunohistochemical images and quantification of CD68 + ( f , g ), CD163 + ( h , i ) and PSGL1 + cells ( j , k ) in control and malignant brain tissue. Bar graphs show mean + individual values. Statistical analysis was performed using paired t -test (* p < 0.05, ** p < 0.01, *** p < 0.001).

Journal: Cancers

Article Title: Immunophenotyping of Circulating and Intratumoral Myeloid and T Cells in Glioblastoma Patients

doi: 10.3390/cancers14235751

Figure Lengend Snippet: Myeloid immune infiltration in glioblastoma tumors. ( a ) schematic overview of intratumoral immune profiling after neurosurgical resection of tumor samples; ( b ) absolute numbers of myeloid cells in tumor samples; ( c ) surface expression of PSGL-1 and PD1 on intratumoral myeloid cells; ( d ) comparison of PSGL-1 and PD1 expression on circulating and tumor-infiltrating myeloid cells; ( e ) Pearson’s correlation of PSGL-1 and PD1 expression on circulating and tumor-infiltrating myeloid cells; ( f – k ) representative immunohistochemical images and quantification of CD68 + ( f , g ), CD163 + ( h , i ) and PSGL1 + cells ( j , k ) in control and malignant brain tissue. Bar graphs show mean + individual values. Statistical analysis was performed using paired t -test (* p < 0.05, ** p < 0.01, *** p < 0.001).

Article Snippet: Before imaging by light microscopy, sections were incubated with antibodies targeting CD68, PSGL-1 (CD162), and CD163 (dilution 1:50; Enzo Life Sciences, Lörrach, Germany) overnight at 4 °C.

Techniques: Expressing, Immunohistochemical staining